复杂联合顺行/逆行再通治疗股腘及膝下动脉闭塞的急性和中期结局评估
回顾性分析888例股腘、膝下或多节段闭塞行联合顺行/逆行再通的患者,技术成功率90.8%-93.8%,围术期并发症率7.2%,24个月一期通畅率30.4%-33.3%,24个月内靶病变血运重建风险31.4%-45.7%。作者认为再通可行,但各部位重复靶病变血运重建率高,适应证可能限于严重肢体威胁性缺血患者。
要点
- 联合顺行/逆行再通治疗股腘、膝下及多节段闭塞的技术成功率为90.8%-93.8%。
- 24个月一期通畅率30.4%-33.3%,24个月内靶病变血运重建风险31.4%-45.7%。
- 透析依赖是再通失败的预测因素(P = .048),病变长度、透析和再通水平增加靶病变血运重建风险。
核心结论
- 使用联合顺行/逆行入路,可在大量病例中实现股腘和/或膝下动脉闭塞的再通。
- 由于所有病变部位重复靶病变血运重建率均高,顺行和逆行再通的适应证可能限于严重肢体威胁性缺血患者。
研究设计与样本
- 回顾性分析接受二次逆行再通尝试的患者,共纳入888例:股腘组(组1)362例,膝下组(组2)353例,多节段组(组3)173例。
- 主要终点为手术成功(使用顺行/逆行技术成功穿过闭塞),次要终点包括并发症率、一期通畅率、靶病变血运重建率、截肢率、踝肱指数和Rutherford-Becker分级变化。
- 分析手术失败和靶病变血运重建的预测因素。
主要发现
- 严重肢体威胁性缺血在组1、组2、组3中分别占36%、62%、76%。
- 手术成功率在组1、组2、组3分别为92.5%、93.8%、90.8%(P = .455)。
- 总体围术期并发症率为7.2%。
- 6、12和24个月一期通畅率组1最高(63.9%、45.8%、33.3%),其次为组3(59.8%、46.1%、33.3%),组2为(58.5%、43.1%、30.4%;P = .537)。
- 24个月内重复靶病变血运重建风险组1为31.4%,组2为39.1%,组3为45.7%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: When antegrade recanalization of femoropopliteal and/or infrapopliteal occlusions fails, retrograde access has become an established option. To evaluate the results of combined antegrade and retrograde recanalization of femoropopliteal and infrapopliteal occlusions, patients undergoing secondary retrograde recanalization attempts were analyzed retrospectively. METHODS: The primary end point was the success of the procedure (successful occlusion crossing using the antegrade/retrograde technique). Secondary end points include complication rate, primary patency and target lesion revascularization (TLR) rate, amputation rate, changes in ankle-brachial index, and Rutherford-Becker class. Predictors for procedure failure and TLR were analyzed. RESULTS: We included 888 patients: 362 with femoropopliteal (group 1), 353 with infrapopliteal (group 2), and 173 with multilevel (group 3) recanalization. Critical limb-threatening ischemia was present in group 1, 2, and 3 in 36%, 62%, and 76% of patients, respectively. The intervention was successful in 92.5%, 93.8%, and 90.8% of the respective cases (P = .455). The overall peri-interventional complication rate was 7.2%. At 6, 12, and 24 months, primary patency was highest in group 1 (63.9%, 45.8%, and 33.3%), followed by group 3 (59.8%, 46.1%, and 33.3%), and group 2 (58.5%, 43.1%, and 30.4%; P = .537). The risk of undergoing repeated TLR within 24 months was 31.4% for group 1, 39.1% for group 2, and 45.7% for group 3. At 24 months, the survival rates in groups 1, 2, and 3 were 93.8%, 79.4%, and 87.5%, respectively. Over 24 months, 75 patients (8.4%) had to undergo amputation. Significant improvements in both ankle-brachial index and Rutherford-Becker class were present at discharge as well as at 6, 12, and 24 months (P < .001). Dialysis dependency was a predictor of unsuccessful antegrade/retrograde recanalization (P = .048). Lesion length (P = .0043), dialysis (P = .033), and recanalization level (P = .013) increase the risk of TLR. CONCLUSIONS: Using a combined antegrade/retrograde access, recanalization of occluded femoropopliteal and/or infrapopliteal arteries can be achieved in a large number of cases. Owing to the high rate of repeated TLR across all lesion localizations, the indication for antegrade and retrograde recanalization may be limited to patients with critical limb-threatening ischemia.
引用
- Noory E, Böhme T, Staus PI, et al. Evaluation of acute and midterm outcomes after complex combined antegrade/retrograde recanalization for occlusions of the femoropopliteal and infrapopliteal arteries. J Vasc Surg. 2024. PMID: 39111587. doi:10.1016/j.jvs.2024.07.099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。